您的位置: 首页 > 农业专利 > 详情页

Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation
专利权人:
Univeristy of Chicago
发明人:
Yuan, Chun-Su,Wang, Chong-Zhi,Gu, Maojian,Lin, Dong-Hai
申请号:
AU2013257211
公开号:
AU2013257211A1
申请日:
2013.03.13
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
A pharmaceutical composition comprising a phosphatidylcholine-based opioid receptor antagonist formulation, as well as methods of their use and methods of their preparation are provided herein. Such pharmaceutical composition may be used for treating and preventing opioid-induced side effects in patients, and may be provided to chronic opioid users as well.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充